NasdaqCM - Nasdaq Real Time Price USD
Bio-Path Holdings, Inc. (BPTH)
As of 2:01 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
13,042.0000
15,843.0000
13,901.0000
10,443.0000
10,908.0000
Operating Income
-13,042.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
Net Non Operating Interest Income Expense
15.0000
36.0000
33.0000
3.0000
26.0000
Other Income Expense
--
-271.0000
--
--
--
Pretax Income
-11,597.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Net Income Common Stockholders
-11,597.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Diluted NI Available to Com Stockholders
-11,597.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Basic EPS
-14.19
-33.63
-38.12
-31.00
-56.60
Diluted EPS
-14.19
-33.63
-38.12
-31.00
-56.60
Basic Average Shares
844.0000
478.0000
364.0000
336.2500
192.3500
Diluted Average Shares
844.0000
478.0000
364.0000
336.2500
192.3500
Total Operating Income as Reported
-13,042.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
Total Expenses
13,042.0000
15,843.0000
13,901.0000
10,443.0000
10,908.0000
Net Income from Continuing & Discontinued Operation
-11,597.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Normalized Income
-13,027.0000
-15,807.0000
-13,868.0000
-10,440.0000
-10,882.0000
Interest Income
15.0000
36.0000
33.0000
3.0000
26.0000
Net Interest Income
15.0000
36.0000
33.0000
3.0000
26.0000
EBIT
-13,042.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
EBITDA
-12,876.0000
-15,665.0000
-13,723.0000
-10,282.0000
-10,757.0000
Reconciled Depreciation
166.0000
178.0000
178.0000
161.0000
151.0000
Net Income from Continuing Operation Net Minority Interest
-11,597.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Total Unusual Items Excluding Goodwill
1,430.0000
-271.0000
--
--
--
Total Unusual Items
1,430.0000
-271.0000
--
--
--
Normalized EBITDA
-14,306.0000
-15,394.0000
-13,723.0000
-10,282.0000
-10,757.0000
12/31/2020 - 3/4/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WINT Windtree Therapeutics, Inc.
0.6042
-12.89%
ADIL Adial Pharmaceuticals, Inc.
0.9979
-1.20%
LIXT Lixte Biotechnology Holdings, Inc.
1.8201
-3.70%
DRMA Dermata Therapeutics, Inc.
1.3600
+7.94%
CMND Clearmind Medicine Inc.
1.3500
-4.26%
VRAX Virax Biolabs Group Limited
1.9000
-4.53%
AZTR Azitra, Inc.
0.4991
+3.80%
SILO Silo Pharma, Inc.
1.1500
+3.63%
HOTH Hoth Therapeutics, Inc.
0.8801
-1.88%
REVB Revelation Biosciences, Inc.
0.8746
+3.11%